Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Abbatemarco, JR"'
Autor:
Abbatemarco, JR1 (AUTHOR) abbatej2@ccf.org, Aboseif, A (AUTHOR), Swetlik, C1 (AUTHOR), Widmar, J1 (AUTHOR), Harvey, T2 (AUTHOR), Kunchok, A1 (AUTHOR), O’Mahony, J1 (AUTHOR), Miller, DM1 (AUTHOR), Conway, DS1 (AUTHOR)
Publikováno v:
Multiple Sclerosis Journal. Aug2024, p1.
Autor:
Abbatemarco, JR1 (AUTHOR), Ambegaonkar, AJ2 (AUTHOR), Raturi, M3 (AUTHOR), Patterson, KR4 (AUTHOR), Patel, H4 (AUTHOR), Park, J4 (AUTHOR)
Publikováno v:
Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS207-S207. 1p.
Autor:
Mahadeen AZ; Department of Neurology (AZM), University of Mississippi Medical Center, Jackson; and Cleveland Clinic Mellen Center (AKC, JAC, RG, JRA, AK), OH., Carlson AK; Department of Neurology (AZM), University of Mississippi Medical Center, Jackson; and Cleveland Clinic Mellen Center (AKC, JAC, RG, JRA, AK), OH., Cohen JA; Department of Neurology (AZM), University of Mississippi Medical Center, Jackson; and Cleveland Clinic Mellen Center (AKC, JAC, RG, JRA, AK), OH., Galioto R; Department of Neurology (AZM), University of Mississippi Medical Center, Jackson; and Cleveland Clinic Mellen Center (AKC, JAC, RG, JRA, AK), OH., Abbatemarco JR; Department of Neurology (AZM), University of Mississippi Medical Center, Jackson; and Cleveland Clinic Mellen Center (AKC, JAC, RG, JRA, AK), OH., Kunchok A; Department of Neurology (AZM), University of Mississippi Medical Center, Jackson; and Cleveland Clinic Mellen Center (AKC, JAC, RG, JRA, AK), OH.
Publikováno v:
Neurology. Clinical practice [Neurol Clin Pract] 2024 Aug; Vol. 14 (4), pp. e200306. Date of Electronic Publication: 2024 May 29.
Autor:
Palmer KN; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA., Sokola M; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA., Uysal SP; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA., Cooperrider J; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA., Leung AK; Department of Infectious Disease, Cleveland Clinic Akron General, Akron, OH, USA., Torres-Trejo A; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA., Li Y; Neuromuscular Center, Cleveland Clinic, Cleveland, OH, USA., Abbatemarco JR; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.
Publikováno v:
The Neurohospitalist [Neurohospitalist] 2024 Jul; Vol. 14 (3), pp. 301-307. Date of Electronic Publication: 2024 Apr 16.
Autor:
Aboseif A; Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA., Maly EF; Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA., Syed FH; Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA., Punia V; Epilepsy Center, Department of Neurology, Cleveland Clinic, Cleveland, Ohio, USA., Kunchok A; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio, USA., Abbatemarco JR; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio, USA ABBATEJ2@ccf.org.
Publikováno v:
Practical neurology [Pract Neurol] 2024 Jun 13. Date of Electronic Publication: 2024 Jun 13.
Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
Autor:
Uysal SP; Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Li Y; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Center for Outcomes Research & Evaluation, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Thompson NR; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Center for Outcomes Research & Evaluation, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Milinovich A; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA., Abbatemarco JR; Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Cohen JA; Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Conway DS; Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Ontaneda D; Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Morren JA; Neuromuscular Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Kunchok A; Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Publikováno v:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Mar; Vol. 11 (3), pp. 710-718. Date of Electronic Publication: 2024 Jan 22.
Autor:
Morgan A; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Li Y; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Thompson NR; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Milinovich A; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Abbatemarco JR; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Cohen JA; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Ontaneda D; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Punia V; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Rae-Grant A; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Galioto R; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH., Kunchok A; From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH.
Publikováno v:
Neurology [Neurology] 2024 Feb 27; Vol. 102 (4), pp. e208019. Date of Electronic Publication: 2024 Jan 24.
Autor:
Abbatemarco JR; Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, United States. Electronic address: abbatej2@ccf.org., Vedeler CA; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, University of Bergen, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Greenlee JE; Neurology Service, George E. Wahlen Veterans Affairs Health Care System, Salt Lake City, UT, United States; Department of Neurology, University of Utah, Salt Lake City, UT, United States.
Publikováno v:
Handbook of clinical neurology [Handb Clin Neurol] 2024; Vol. 200, pp. 173-191.
Autor:
Galioto R; From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany. galiotr@ccf.org., Grezmak T; From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany., Swetlik C; From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany., Abbatemarco JR; From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany., Titulaer MJ; From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany., Finke C; From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany., Kunchok A; From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2023 Nov 10; Vol. 11 (1). Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2024).
Autor:
Aboseif A; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Li Y; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Amin M; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Lapin B; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Milinovich A; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Abbatemarco JR; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Cohen JA; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Punia V; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Rae-Grant AD; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Galioto R; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH., Kunchok A; From the Department of Neurology (A.A.), Neurological Institute; Department of Quantitative Health Sciences (Y.L., B.L., A.M.), Lerner Research Institute; Center for Outcomes Research and Evaluation (Y.L., B.L.); Mellen Center for Multiple Sclerosis Treatment and Research (M.A., J.R.A., J.A.C., A.K.); Epilepsy Center (V.P.), Neurologic Institute, Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.D.R.-G.), OH. kunchoa@ccf.org.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2023 Nov 10; Vol. 11 (1). Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2024).